REVUMENIB Pharmacologic Class Indexing
- Class set ID
- 4c53bdd6-2b3e-4344-9c0d-6ebcb6c8e28c
- Version
- 1
- Effective date
- 20250728
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use REVUFORJ safely and effectively. See full prescribing information for REVUFORJ. REVUFORJ (revumenib) tablets for oral use Initial U.S. Approval: 2024 | Syndax Pharmaceuticals, Inc. | 20260204 | 5 |